X‐Ray‐Triggered CO‐Release from Gold Nanocluster: All‐in‐One Nanoplatforms for Cancer Targeted Gas and Radio Synergistic Therapy
Source abstract
Abstract
Abstract Glycolysis‐dominant metabolic pathway in cancer cells can promote their therapeutic resistance against radiotherapy (RT). Carbon monoxide (CO) as a glycolysis inhibitor can enhance the efficiency of RT. Herein, an X‐ray responsive CO‐releasing nanocomposite (HA@AuNC@CO) based on strong host–guest interactions between the radiosensitizer and CO donor for enhanced RT is developed. The encapsulated gold nanoclusters (CD‐AuNCs) can effectively generate cytotoxic reactive oxygen species (ROS) under X‐ray radiation, which not only directly inactivate cancer cells but also induce in situ CO gas generation from adamantane modified metal carbonyl (Ada‐CO) for glycolysis inhibition. Both in vitro and in vivo results demonstrate that HA@AuNC@CO exhibits active targeting toward CD44 overexpressed cancer cells, along with excellent inhibition of glycolysis and efficient RT against cancer. This study offers a new strategy for the combination of gas therapy and RT in tumor treatment.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Heme Oxygenase-1 and Carbon Monoxide · Nanoplatforms for cancer theranostics · Hemoglobin structure and function
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Joint School of National University of Singapore and Tianjin University International Campus of Tianjin University Fuzhou 350207 P. R. China
Department of Chemical and Biomolecular Engineering National University of Singapore Singapore 117585 Singapore
MOE Key Laboratory for Analytical Science of Food Safety and Biology College of Chemistry Fuzhou University Fuzhou 350108 P. R. China
Funding
National University of Singapore · National Research Foundation Singapore · National Natural Science Foundation of China
References (49)
Show source-provided references
1. Schaue D. · Clin. Oncol. · 2015 · 12 · 527
2. 10.1039/D3MH00265A10.1039/D3MH00265A ↗
3. 10.1021/acsnano.6b0140110.1021/acsnano.6b01401 ↗
4. 10.1038/nrc300710.1038/nrc3007 ↗
5. 10.7150/ijms.363510.7150/ijms.3635 ↗
6. 10.1002/adma.20170099610.1002/adma.201700996 ↗
7. 10.1039/D1SC03997K10.1039/D1SC03997K ↗
8. 10.1016/j.cclet.2022.02.04910.1016/j.cclet.2022.02.049 ↗
9. 10.1186/s12951-022-01694-110.1186/s12951-022-01694-1 ↗
10. 10.3390/ijms2403260610.3390/ijms24032606 ↗
11. 10.1021/acs.nanolett.2c0247210.1021/acs.nanolett.2c02472 ↗
12. 10.1016/j.mtnano.2022.10025310.1016/j.mtnano.2022.100253 ↗
13. 10.1038/nrd322810.1038/nrd3228 ↗
14. 10.1002/smll.20190438210.1002/smll.201904382 ↗
15. 10.2174/13892011280039932910.2174/138920112800399329 ↗
16. 10.1016/j.canlet.2022.21583110.1016/j.canlet.2022.215831 ↗
17. 10.1002/anie.20230252510.1002/anie.202302525 ↗
18. 10.1002/1873-3468.1243410.1002/1873-3468.12434 ↗
19. 10.1158/0008-5472.CAN-13-107510.1158/0008-5472.CAN-13-1075 ↗
20. 10.1038/s41467-019-09158-110.1038/s41467-019-09158-1 ↗
21. 10.1016/j.biomaterials.2023.12231310.1016/j.biomaterials.2023.122313 ↗
22. 10.1002/anie.20221167410.1002/anie.202211674 ↗
23. 10.1113/jphysiol.1912.sp00151710.1113/jphysiol.1912.sp001517 ↗
24. 10.1002/adtp.20180008410.1002/adtp.201800084 ↗
25. 10.1021/jacs.7b0086710.1021/jacs.7b00867 ↗
26. 10.1002/adma.20180196410.1002/adma.201801964 ↗
27. 10.1039/C5BM00210A10.1039/C5BM00210A ↗
28. 10.1021/ja00513a01910.1021/ja00513a019 ↗
29. 10.1021/ja00356a04710.1021/ja00356a047 ↗
30. 10.1021/ic902147n10.1021/ic902147n ↗
31. 10.2147/IJN.S39825410.2147/IJN.S398254 ↗
32. 10.1039/C7MH00451F10.1039/C7MH00451F ↗
33. 10.2147/IJN.S27290210.2147/IJN.S272902 ↗
34. 10.1002/anie.20201087010.1002/anie.202010870 ↗
35. 10.1039/C6CP02770A10.1039/C6CP02770A ↗
36. 10.1002/anie.20200103410.1002/anie.202001034 ↗
37. 10.1039/C4CC04533E10.1039/C4CC04533E ↗
38. 10.1021/es061780010.1021/es0617800 ↗
39. 10.1039/C7CC01576C10.1039/C7CC01576C ↗
40. 10.1126/sciadv.aba136210.1126/sciadv.aba1362 ↗
41. 10.1038/s41557-018-0055-210.1038/s41557-018-0055-2 ↗
42. 10.1021/acs.nanolett.7b0138210.1021/acs.nanolett.7b01382 ↗
43. 10.1021/acsami.8b0920010.1021/acsami.8b09200 ↗
44. 10.1021/acs.analchem.7b0013510.1021/acs.analchem.7b00135 ↗
45. 10.1002/adma.20150276210.1002/adma.201502762 ↗
46. 10.1007/s11051-018-4324-110.1007/s11051-018-4324-1 ↗
47. 10.1021/acs.molpharmaceut.9b0008310.1021/acs.molpharmaceut.9b00083 ↗
48. 10.1007/s00018-019-03398-610.1007/s00018-019-03398-6 ↗
49. Queiroga C. S. F. · Biochem. Res. Int. · 2014 · 2012